The CancerWeb Report, What's New In Cancer: February, 1996
Testicular germ cell cancer

• Non-Seminomatous Testicular Cancer - A report from the Kaiser Franz Josef Hospital, Vienna, Austria, described adjuvant therapy with two courses of cisplatin, etoposide and bleomycin as an effective treatment for patients with non-seminomatous testicular cancer. Twenty-nine patients were followed up of 42 treated for clinical stage I disease, but who had a high risk of relapse because tumor had invaded the blood vessels. No significant adverse effects were seen within a median follow-up time of over six years. (Pont, J Clin Oncol 14:441, 1996)